References
Lance JW (1980) Symposium synopsis. In: Feldman RG, Young RR, Koella WP (eds) Spasticity-disordered motor control. Mosby Year Book, St. Louis, pp 485–494
Donovan WH, Carter RE, Rossi CD, Wilerson MA (1988) Clonidine effect on spasticity: a clinical trial. Arch Phys Med Rehabil 69:193–195
Maynard FM (1986) Early clinical experience with clonidine in spinal spasticity. Paraplegia 24:175–182
Nance PW, Shears AH, Nance DM (1985) Clonidine in spinal cord injury. Can Med Assoc J 133:41–42
Nance PW, Shears AIL, Nance DM (1989) Reflex change induced by clonidine in spinal cord injured patients. Paraplegia 27:296–301
Sanford PR, Spengler SE, Sawasky KB (1992) Clonidine in the treatment of brainstem spasticity. Am J Phys Med Rehabil 71:301–303
Weingarden SI, Belen JG (1992) Clonidine transdermal system for treatment of spasticity in spinal cord injury. Arch Phys Med Rehabil 73:876–877
Marshall KC, Engberg I (1979) Reversal potential for noradrenaline induced hyperpolarization of spinal motoneurons. Science 205:422–424
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Khan, O.A., Olek, M.J. Clonidine in the treatment of spasticity in patients with multiple sclerosis. J Neurol 242, 712–713 (1995). https://doi.org/10.1007/BF00866925
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00866925